Third Australian report on antimicrobial use and resistance in human health

  10 May 2019

The Antimicrobial Use and Resistance in Australia (AURA) Surveillance  system provides data and information to support Australia’s strategic response to one of the most significant challenges facing health care
around the world: antimicrobial resistance (AMR).

AMR reduces the range of antimicrobials available to treat infections, and increases morbidity and mortality associated with infections caused by multidrug-resistant organisms. AMR is well established as a priority for action due to its serious and growing impact on human health.

Further reading: AURA 2019 (full report)
Effective Surveillance  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University

Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!